Global and Europe Psoriasis Therapeutic Market Professional Survey Report 2019

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Global Psoriasis Therapeutic market was valued at XX.0 million US$ in 2018, with the CAGR of 12.7%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe Psoriasis Therapeutic market. Describe product range of Psoriasis Therapeutic, market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe Psoriasis Therapeutic market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe Psoriasis Therapeutic market.

     

    By Player

    • AstraZeneca

    • Aurinia Pharmaceuticals

    • Boehringer Ingelheim

    • Biotest

    • Amgen

    • Bristol-Myers Squibb

    • Coherus Biosciences

    • Dermira

    • Astellas Pharma

    • Biogen Idec

    • Janssen Pharmaceuticals

    • Biocon

    • AbGenomics

    • Anacor Pharmaceuticals

    • Can-Fite BioPharma

    • Celgene

    • ApoPharma

    • Abbvie

    • Creabilis

    • Almirall

    • Pfizer

    By Type

    • TNF Inhibitors

    • PDE4 Inhibitors

    • Interleukin Blockers

    By End-User

    • End-User 1

    • End-User 2

    • End-User 3

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Psoriasis Therapeutic Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global Psoriasis Therapeutic Market Size and Growth Rate of TNF Inhibitors from 2014 to 2026

      • 1.3.2 Global Psoriasis Therapeutic Market Size and Growth Rate of PDE4 Inhibitors from 2014 to 2026

      • 1.3.3 Global Psoriasis Therapeutic Market Size and Growth Rate of Interleukin Blockers from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global Psoriasis Therapeutic Market Size and Growth Rate of End-User 1 from 2014 to 2026

      • 1.4.2 Global Psoriasis Therapeutic Market Size and Growth Rate of End-User 2 from 2014 to 2026

      • 1.4.3 Global Psoriasis Therapeutic Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Psoriasis Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Psoriasis Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Psoriasis Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Psoriasis Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Psoriasis Therapeutic Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Psoriasis Therapeutic by Major Types

      • 3.4.1 Market Size and Growth Rate of TNF Inhibitors

      • 3.4.2 Market Size and Growth Rate of PDE4 Inhibitors

      • 3.4.3 Market Size and Growth Rate of Interleukin Blockers

    4 Segmentation of Psoriasis Therapeutic Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Psoriasis Therapeutic by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Psoriasis Therapeutic for End-User 1

      • 4.4.2 Market Size and Growth Rate of Psoriasis Therapeutic for End-User 2

      • 4.4.3 Market Size and Growth Rate of Psoriasis Therapeutic for End-User 3

    5 Market Analysis by Major Regions

    • 5.1 Global Psoriasis Therapeutic Production Analysis by Top Regions

    • 5.2 Global Psoriasis Therapeutic Consumption Analysis by Top Regions

    • 5.3 Global Psoriasis Therapeutic Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Psoriasis Therapeutic Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Psoriasis Therapeutic Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Psoriasis Therapeutic Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Psoriasis Therapeutic Production, Import, Consumption and Export Analysis

    6 Product Circulation of Psoriasis Therapeutic Market among Top Countries

    • 6.1 Top 5 Export Countries in Psoriasis Therapeutic Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Psoriasis Therapeutic Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Psoriasis Therapeutic Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Psoriasis Therapeutic Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Psoriasis Therapeutic Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Psoriasis Therapeutic Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Psoriasis Therapeutic Landscape Analysis

    • 7.1 North America Psoriasis Therapeutic Landscape Analysis by Top Countries

      • 7.1.1 United States Psoriasis Therapeutic Market Volume and Growth Rate

      • 7.1.2 Canada Psoriasis Therapeutic Market Volume and Growth Rate

      • 7.1.3 Mexico Psoriasis Therapeutic Market Volume and Growth Rate

    8. Europe Psoriasis Therapeutic Landscape Analysis

    • 8.1 Europe Psoriasis Therapeutic Landscape Analysis by Major Types

    • 8.2 Europe Psoriasis Therapeutic Landscape Analysis by Major End-Users

    • 8.3 Europe Psoriasis Therapeutic Landscape Analysis by Top Countries

      • 8.3.1 Germany Psoriasis Therapeutic Market Volume and Growth Rate

      • 8.3.2 UK Psoriasis Therapeutic Market Volume and Growth Rate

      • 8.3.3 France Psoriasis Therapeutic Market Volume and Growth Rate

      • 8.3.4 Italy Psoriasis Therapeutic Market Volume and Growth Rate

      • 8.3.5 Spain Psoriasis Therapeutic Market Volume and Growth Rate

      • 8.3.6 Belgium Psoriasis Therapeutic Market Volume and Growth Rate

      • 8.3.7 Poland Psoriasis Therapeutic Market Volume and Growth Rate

      • 8.3.8 Russia Psoriasis Therapeutic Market Volume and Growth Rate

      • 8.3.9 Turkey Psoriasis Therapeutic Market Volume and Growth Rate

      • 8.3.10 Netherlands Psoriasis Therapeutic Market Volume and Growth Rate

      • 8.3.11 Portugal Psoriasis Therapeutic Market Volume and Growth Rate

      • 8.3.12 Denmark Psoriasis Therapeutic Market Volume and Growth Rate

      • 8.3.13 Finland Psoriasis Therapeutic Market Volume and Growth Rate

      • 8.3.14 Iceland Psoriasis Therapeutic Market Volume and Growth Rate

      • 8.3.15 Norway Psoriasis Therapeutic Market Volume and Growth Rate

      • 8.3.16 Sweden Psoriasis Therapeutic Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Psoriasis Therapeutic Landscape Analysis

    • 9.1 Asia Pacific Psoriasis Therapeutic Landscape Analysis by Top Countries

      • 9.1.1 China Psoriasis Therapeutic Market Volume and Growth Rate

      • 9.1.2 Japan Psoriasis Therapeutic Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Psoriasis Therapeutic Market Volume and Growth Rate

      • 9.1.4 India Psoriasis Therapeutic Market Volume and Growth Rate

      • 9.1.5 ASEAN Psoriasis Therapeutic Market Volume and Growth Rate

      • 9.1.6 South Korea Psoriasis Therapeutic Market Volume and Growth Rate

    10 LAMEA Psoriasis Therapeutic Landscape Analysis

    • 10.1 LAMEA Psoriasis Therapeutic Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Psoriasis Therapeutic Market Volume and Growth Rate

      • 10.1.2 Brazil Psoriasis Therapeutic Market Volume and Growth Rate

      • 10.1.3 North Africa Psoriasis Therapeutic Market Volume and Growth Rate

      • 10.1.4 South Africa Psoriasis Therapeutic Market Volume and Growth Rate

      • 10.1.5 Argentina Psoriasis Therapeutic Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 AstraZeneca

      • 11.1.1 AstraZeneca Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Aurinia Pharmaceuticals

      • 11.2.1 Aurinia Pharmaceuticals Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Boehringer Ingelheim

      • 11.3.1 Boehringer Ingelheim Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Biotest

      • 11.4.1 Biotest Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Amgen

      • 11.5.1 Amgen Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Bristol-Myers Squibb

      • 11.6.1 Bristol-Myers Squibb Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Coherus Biosciences

      • 11.7.1 Coherus Biosciences Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Dermira

      • 11.8.1 Dermira Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Astellas Pharma

      • 11.9.1 Astellas Pharma Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Biogen Idec

      • 11.10.1 Biogen Idec Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Janssen Pharmaceuticals

      • 11.11.1 Janssen Pharmaceuticals Company Profile and Development Status

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Biocon

      • 11.12.1 Biocon Company Profile and Development Status

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 AbGenomics

      • 11.13.1 AbGenomics Company Profile and Development Status

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Anacor Pharmaceuticals

      • 11.14.1 Anacor Pharmaceuticals Company Profile and Development Status

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Can-Fite BioPharma

      • 11.15.1 Can-Fite BioPharma Company Profile and Development Status

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Celgene

      • 11.16.1 Celgene Company Profile and Development Status

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 ApoPharma

      • 11.17.1 ApoPharma Company Profile and Development Status

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Abbvie

      • 11.18.1 Abbvie Company Profile and Development Status

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 Creabilis

      • 11.19.1 Creabilis Company Profile and Development Status

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction

    • 11.20 Almirall

      • 11.20.1 Almirall Company Profile and Development Status

      • 11.20.2 Market Performance

      • 11.20.3 Product and Service Introduction

    • 11.21 Pfizer

      • 11.21.1 Pfizer Company Profile and Development Status

      • 11.21.2 Market Performance

      • 11.21.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 95 Figures and 163 Tables)

    • Figure Product Picture

    • Figure Global Psoriasis Therapeutic Market Size and Growth Rate of TNF Inhibitors from 2014 to 2026

    • Figure Global Psoriasis Therapeutic Market Size and Growth Rate of PDE4 Inhibitors from 2014 to 2026

    • Figure Global Psoriasis Therapeutic Market Size and Growth Rate of Interleukin Blockers from 2014 to 2026

    • Figure Global Psoriasis Therapeutic Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Global Psoriasis Therapeutic Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Global Psoriasis Therapeutic Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure North America Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure United States Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure UK Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure France Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure China Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure India Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Psoriasis Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Psoriasis Therapeutic Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Psoriasis Therapeutic

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Psoriasis Therapeutic by Different Types from 2014 to 2026

    • Table Consumption Share of Psoriasis Therapeutic by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of TNF Inhibitors

    • Figure Market Size and Growth Rate of PDE4 Inhibitors

    • Figure Market Size and Growth Rate of Interleukin Blockers

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Psoriasis Therapeutic by Different End-Users from 2014 to 2026

    • Table Consumption Share of Psoriasis Therapeutic by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Global Psoriasis Therapeutic Production by Major Regions

    • Table Global Psoriasis Therapeutic Production Share by Major Regions

    • Table Global Psoriasis Therapeutic Consumption by Major Regions

    • Table Global Psoriasis Therapeutic Consumption Share by Major Regions

    • Table North America Psoriasis Therapeutic Production, Import, Consumption and Export Analysis

    • Table Europe Psoriasis Therapeutic Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Psoriasis Therapeutic Production, Import, Consumption and Export Analysis

    • Table LAMEA Psoriasis Therapeutic Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Psoriasis Therapeutic Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Psoriasis Therapeutic Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Psoriasis Therapeutic Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Psoriasis Therapeutic Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Psoriasis Therapeutic Consumption by Major Countries from 2014 to 2026

    • Table North America Psoriasis Therapeutic Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Psoriasis Therapeutic Consumption Share by Major Countries in 2014

    • Figure North America Psoriasis Therapeutic Consumption Share by Major Countries in 2018

    • Figure North America Psoriasis Therapeutic Consumption Share by Major Countries in 2026

    • Figure United States Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Psoriasis Therapeutic Consumption by Types from 2014 to 2026

    • Table Europe Psoriasis Therapeutic Consumption Share by Types from 2014 to 2026

    • Table Europe Psoriasis Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Europe Psoriasis Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Table Europe Psoriasis Therapeutic Consumption by Major Countries from 2014 to 2026

    • Table Europe Psoriasis Therapeutic Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure France Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Psoriasis Therapeutic Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Psoriasis Therapeutic Consumption Share by Major Countries from 2014 to 2026

    • Figure China Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure India Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Psoriasis Therapeutic Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Psoriasis Therapeutic Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Psoriasis Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Aurinia Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurinia Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Aurinia Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Aurinia Pharmaceuticals

    • Table Product and Service Introduction of Aurinia Pharmaceuticals

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Biotest

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotest

    • Figure Sales and Growth Rate Analysis of Biotest

    • Figure Revenue and Market Share Analysis of Biotest

    • Table Product and Service Introduction of Biotest

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Bristol-Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

    • Table Product and Service Introduction of Bristol-Myers Squibb

    • Table Company Profile and Development Status of Coherus Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Coherus Biosciences

    • Figure Sales and Growth Rate Analysis of Coherus Biosciences

    • Figure Revenue and Market Share Analysis of Coherus Biosciences

    • Table Product and Service Introduction of Coherus Biosciences

    • Table Company Profile and Development Status of Dermira

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dermira

    • Figure Sales and Growth Rate Analysis of Dermira

    • Figure Revenue and Market Share Analysis of Dermira

    • Table Product and Service Introduction of Dermira

    • Table Company Profile and Development Status of Astellas Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma

    • Figure Sales and Growth Rate Analysis of Astellas Pharma

    • Figure Revenue and Market Share Analysis of Astellas Pharma

    • Table Product and Service Introduction of Astellas Pharma

    • Table Company Profile and Development Status of Biogen Idec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Idec

    • Figure Sales and Growth Rate Analysis of Biogen Idec

    • Figure Revenue and Market Share Analysis of Biogen Idec

    • Table Product and Service Introduction of Biogen Idec

    • Table Company Profile and Development Status of Janssen Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Janssen Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Janssen Pharmaceuticals

    • Table Product and Service Introduction of Janssen Pharmaceuticals

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

    • Table Company Profile and Development Status of AbGenomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbGenomics

    • Figure Sales and Growth Rate Analysis of AbGenomics

    • Figure Revenue and Market Share Analysis of AbGenomics

    • Table Product and Service Introduction of AbGenomics

    • Table Company Profile and Development Status of Anacor Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anacor Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Anacor Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Anacor Pharmaceuticals

    • Table Product and Service Introduction of Anacor Pharmaceuticals

    • Table Company Profile and Development Status of Can-Fite BioPharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Can-Fite BioPharma

    • Figure Sales and Growth Rate Analysis of Can-Fite BioPharma

    • Figure Revenue and Market Share Analysis of Can-Fite BioPharma

    • Table Product and Service Introduction of Can-Fite BioPharma

    • Table Company Profile and Development Status of Celgene

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene

    • Figure Sales and Growth Rate Analysis of Celgene

    • Figure Revenue and Market Share Analysis of Celgene

    • Table Product and Service Introduction of Celgene

    • Table Company Profile and Development Status of ApoPharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ApoPharma

    • Figure Sales and Growth Rate Analysis of ApoPharma

    • Figure Revenue and Market Share Analysis of ApoPharma

    • Table Product and Service Introduction of ApoPharma

    • Table Company Profile and Development Status of Abbvie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbvie

    • Figure Sales and Growth Rate Analysis of Abbvie

    • Figure Revenue and Market Share Analysis of Abbvie

    • Table Product and Service Introduction of Abbvie

    • Table Company Profile and Development Status of Creabilis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Creabilis

    • Figure Sales and Growth Rate Analysis of Creabilis

    • Figure Revenue and Market Share Analysis of Creabilis

    • Table Product and Service Introduction of Creabilis

    • Table Company Profile and Development Status of Almirall

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Almirall

    • Figure Sales and Growth Rate Analysis of Almirall

    • Figure Revenue and Market Share Analysis of Almirall

    • Table Product and Service Introduction of Almirall

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.